Exhibit 99.6

Reconciliation of Lauro 57 Reported EBITDA to Euticals Adjusted EBITDA

(in € thousands)

	2013			2014			2015
As Reported EBITDA (IFRS) - Lauro 57	€	21,383		€	21,627		€	29,564
+ Severance Charges		2,547			400
+ Consulting & Acquisition Costs		1,016
+ Prior Year Extraordinary Items		294			1,000
+ Bank Commissions		793			909			692
+ Change in Environmental Provision		795			(543	)
+ Provision Allocation		1,080			124
+ Provision for Receivables		2,450			192
+ R&D Write-off		1,043
+ Non-Cash Employee Benefits Impact		(236	)		(141	)
Adjusted EBITDA (IFRS) - Lauro 57	€	31,164		€	23,567		€	30,256
+ Holding Company Costs		168			60			220
Adjusted EBITDA (IFRS) - Euticals	€	31,333		€	23,627		€	30,476
- Capitalized R&D Costs		(3,072	)		(4,957	)		(4,664	)
- Bank Commissions		(793	)		(909	)		(692	)
Adjusted EBITDA - Euticals	€	27,467		€	17,761		€	25,120
Euro to USD FX Translation Rate		1.130			1.130			1.130
Adjusted EBITDA - Euticals	$	31,038		$	20,070		$	28,386